ISSN 1662-4009 (online)

ey0015.12-11 | New Imaging | ESPEYB15

12.11 Ultrasonographic Quantitative Analysis of Fatty Pancreas in Obese Children: Its Correlation with Metabolic Syndrome and Homeostasis Model Assessment of Insulin Resistance

DR Kim , MS Lee , JS Lee , GM Choi , KS Kang

To read the full abstract: J Pediatr 2018;193:134-138.e1Obesity promotes visceral fat deposition, which may result in profound metabolic consequences that contribute directly to insulin resistance, and risk of cardiovascular disease and malignancy. Obese individuals are at increased risk of fatty liver disease, which can lead to steatohepatitis and subsequently advanced liver fibrosis. Less...

ey0017.8-14 | New Concerns | ESPEYB17

8.14. Brain differences in the prefrontal cortex, amygdala, and hippocampus in youth with congenital adrenal hyperplasia

MM Herting , A Azad , R Kim , JM Tyszka , ME Geffner , MS Kim

To read the full abstract: J Clin Endocrinol Metab. 2020; 105(4):1098-111. PMID: 31950148.Classical congenital adrenal hyperplasia (CAH) is characterized by impaired glucocorticoid, and often also mineralocorticoid, secretion and increased adrenal androgen production (1). Given the widespread expression of androgen and glucocorticoid receptors throughout the brain (...

ey0015.1-3 | New mechanisms | ESPEYB15

1.3 Hypothalamic stem cells control ageing speed partly through exosomal miRNAs

Y Zhang , MS Kim , B Jia , J Yan , JP Zuniga-Hertz , C Han , D Cai

To read the full abstract: Nature 2017;548:52-57The central nervous system contributes to ageing. The hypothalamus seems to be particularly important in this process. Recent studies have demonstrated a link between ageing and a decrease of neurogenesis in the hippocampus and the subventricular zone of the lateral ventricle in the brain. Neural stem/progenitor cells (NSC) reside in those regions in ...

ey0019.8-7 | Important for Clinical Practice | ESPEYB19

8.7. Low adrenomedullary function predicts acute illness in infants with classical Congenital Adrenal Hyperplasia

J Weber , VK Tanawattanacharoen , A Seagroves , MC Liang , CM Koppin , HM Ross , TASS Bachega , ME Geffner , M Serrano-Gonzalez , G Bhullar , MS Kim

J Clin Endocrinol Metab. 2022; 107(1): e264–e271. PMID: 34397083https://pubmed.ncbi.nlm.nih.gov/34397083/ Brief Summary: This prospective cohort study determined plasma epinephrine concentrations in infants with classic CAH, and showed that the lower epinephrine reseve is associated with increased risk of illness.Children and adolescents with classical Congenital ...

ey0021.8-11 | Clinical Trials – New Treatments | ESPEYB21

8.11. Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia

K Sarafoglou , MS Kim , M Lodish , EI Felner , L Martinerie , NJ Nokoff , M Clemente , PY Fechner , MG Vogiatzi , PW Speiser , RJ Auchus , GBG Rosales , E Roberts , GS Jeha , RH Farber , JL Chan , Investigators Cahtalyst Pediatric Trial

Brief Summary: This phase 3, multinational, randomized clinical trial (CAHtalyst, NCT04806451) in pediatric patients with CAH, evaluated the efficacy of crinecerfont to improve androgen control and enable GC dose reduction to a physiological range.Comment: Congenital adrenal hyperplasia (CAH) comprises several rare autosomal recessive conditions resulting in disordered adrenal steroidogenesis. Pathogenic variants in the CYP21A2 gene encoding ste...